Laccona Nicholas 4
4 · Bellerophon Therapeutics, Inc. · Filed Jan 28, 2022
Insider Transaction Report
Form 4
Laccona Nicholas
Controller, (PFO & PAO)
Transactions
- Award
Restricted Stock Units
2022-01-26+36,000→ 36,000 totalExercise: $0.00→ Common Stock (36,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive, upon vesting of the unit, one share of Bellerophon common stock. The restricted stock units are scheduled to vest 50% on December 9, 2022 and 50% on December 8, 2023, as long as the reporting person remains in the service of Bellerophon through the respective vesting date.
- [F2]Not applicable.